A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function
Clinical trial NCT02436447 · COMPLETED
Trial details
- NCT number
- NCT02436447
- Sponsor
- Stealth BioTherapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2015-07-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.